Feb 12, 2021
In this episode of The Moss Report Podcast, Ralph W. Moss speaks with Dr. Robert Nagourney about his well-documented approach to precision oncology. Nagourney’s strategy takes a step away from genetic sequencing. By taking a biopsy of a tumor, he claims to be able to deduce what treatments will be effective for an individual. Also in this episode is a discussion about repurposed drugs for cancer treatment, including the use of Metformin.
Robert A. Nagourney, MD, is Medical and Laboratory Director of The Nagourney Cancer Institute in Long Beach, California, and an Associate Clinical Professor, at the University of California Irvine. He is board-certified in internal medicine, medical oncology, and hematology.
Learn more about Dr. Nagourney's work at www.nagourneycancerinstitute.com/
Learn more about Dr. Moss's work at